UNVERIFIEDSingle SourceSTAT+: Sarepta names Michael Severino, former Tessera CEO, as new chief executiveStat News|7/27/2026
UNVERIFIEDSingle SourceSTAT+: Ahead of hearing, FDA questions the efficacy of Capricor’s Duchenne drugStat News|7/27/2026
UNVERIFIEDSingle SourceSTAT+: RA Capital backs upstart rival to Ultragenyx and Ionis in rare brain diseaseStat News|7/27/2026